We and others have shown that a subset of SLE patients have elevated levels of serum GM-CSF [36, 37], particularly those with active disease, which could also increase the proportion of immature neutrophils leaving the bone marrow in patients with active SLE. The gene discussed is CSF2; the disease is systemic lupus erythematosus.